POLAREAN, INC.

DURHAM, NC · Founded 2011 · Medtech · Private

Hyperpolarized 129Xe MRI polarizer and imaging system for regional lung function assessment

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · polarean.com

Sector: Medtech
Headquarters: DURHAM, NC
Founded: 2011
Latest Form D: $1.9M, Sep 2015
Total capital: $5.4M

Federal grants: $3M; 3 awards · 2017–2019; Rank in peer group#356 of 538
Private capital raised: $2.4M; 3 Form D · last Sep 2015; 134 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 10 pending

Capital timeline

Latest events

Apr 2019Federal grantHealth and Human S · Phase II · A Phase III Trial to Validate HP 129Xe MRI as a Functional Pulmonary Biomarker in Pediatric Lung Disease$979K
Mar 2018Federal grantHealth and Human S · Phase II · A Phase III Trial to Validate HP 129Xe MRI as a Functional Pulmonary Biomarker in Pediatric Lung Disease$999K
Apr 2017Federal grantHealth and Human S · Phase II · A Phase III Trial to Validate HP 129Xe MRI as a Functional Pulmonary Biomarker in Pediatric Lung Disease$1.0M
Sep 2015Private capital raisedForm D · SEC · 3rd filing$1.9M
Apr 2015Private capital raisedForm D · SEC · 2nd filing$250K
Feb 2012Private capital raisedForm D · SEC · 1st filing$250K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

Bastiaan J. DriehuysExecutive Officer, DirectorNamed in SEC Form D filings
DAN DEATONDirectorNamed in SEC Form D filings
Daniel M. DeatonDirectorNamed in SEC Form D filings
JAYE MCDERMOTTExecutive OfficerNamed in SEC Form D filings
JOHN J. SUDOLDirectorNamed in SEC Form D filings
KENNETH WESTExecutive OfficerNamed in SEC Form D filings

Show all 7 people

SARA P. SHELPExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 10

Apr 30, 2026PendingHyperpolarizers With A Load-lock Chamber For Alkali MetalUSPTOApplication 19003184
Sep 26, 2024PendingSystems For Automated Volumetry, Blending And Dispensing Of GasUSPTOApplication 18593254
Aug 22, 2024PendingTransport Containers With Permanent Magnets And Associated MethodsUSPTOApplication 18436641

Show all 10 patent records

Hyperpolarizers With A Load-lock Chamber For Alkali MetalApr 30, 2026 · Application 19003184Pending
Systems For Automated Volumetry, Blending And Dispensing Of GasSep 26, 2024 · Application 18593254Pending
Transport Containers With Permanent Magnets And Associated MethodsAug 22, 2024 · Application 18436641Pending
Cryo-collection Systems, Related Methods And Hyperpolarizers With The Cryo-collection SystemsAug 15, 2024 · Application 18433767Pending
Cryo-collection Systems And Related Methods And Hyperpolarizer SystemsAug 15, 2024 · Application 18433770Pending
Transport Containers With Permanent Magnets And Associated MethodsApplication PCTUS2024014972Pending
Systems For Automated Volumetry, Blending And Dispensing Of GasApplication PCTUS2024018085Pending
Hyperpolarizers With A Load-lock Chamber For Alkali MetalApplication PCTUS2024062036Pending
Cryo-collection Systems, Related Methods And Hyperpolarizers With The Cryo-collection SystemsApplication PCTUS2024014566Pending
Cryo-collection Systems And Related Methods And Hyperpolarizer SystemsApplication PCTUS2024014568Pending

NEUROLIGN USA, LLCSimilar federal contract value in Medtech · null in contracts
ELORAC, INC.Similar federal contract value in Medtech · null in contracts
CELESTIAL ONCOLOGY INC.Similar federal contract value in Medtech · null in contracts
Emboline IncSimilar federal contract value in Medtech · null in contracts
Endeavor Orthopaedics, Inc.Similar federal contract value in Medtech · null in contracts
Momentum Women LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.